LinusBio
Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. The company offers a temporal exposome sequencing technology, enablin...
Valuation
$0
Share Price
N/A
Total Raised
$34.6M
Last Round
N/A